MedPath

Research of serum biomarker for pancreatic or bile duct cancers using peptide analysis

Not Applicable
Recruiting
Conditions
pancreatic cancer, bile duct cancer
Registration Number
JPRN-UMIN000040276
Lead Sponsor
niverstiy of Toyama
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1 Patients with high risk of complications from blood sampling. 2 Patients who do not or can not give informed consent.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Peptide analysis using BLOTCHIP
Secondary Outcome Measures
NameTimeMethod
1 Pathological diagnosis 2 Imaging diagnosis 3 Clinical stage
© Copyright 2025. All Rights Reserved by MedPath